Somatostatin receptor scintigraphy with In-111-octreotide in pulmonary carcinoid tumours correlated with pathological and (18)FDG PET/CT findings

Kuyumcu, SERKAN; Adalet, Işık; Sanli, Yasemin; Turkmen, Cüneyt; Ozkan, ZEYNEP; Yilmazbayhan, Dilek

doi:10.1007/s12149-012-0628-x

Somatostatin receptor scintigraphy with In-111-octreotide in pulmonary carcinoid tumours correlated with pathological and (18)FDG PET/CT findings

Kuyumcu S., Adalet I., Sanli Y., Turkmen C., Ozkan Z. G., Yilmazbayhan D.

ANNALS OF NUCLEAR MEDICINE, cilt.26, sa.9, ss.689-697, 2012 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 26 Sayı: 9
Basım Tarihi: 2012
Doi Numarası: 10.1007/s12149-012-0628-x
Dergi Adı: ANNALS OF NUCLEAR MEDICINE
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.689-697
Anahtar Kelimeler: Pulmonary carcinoid, Somatostatin receptor scintigraphy, FDG PET, Ki-67, POSITRON-EMISSION-TOMOGRAPHY, NEUROENDOCRINE TUMORS, LUNG, MANAGEMENT, SURVIVAL
İstanbul Üniversitesi Adresli: Evet

Özet

Pulmonary carcinoid (PC) tumors are rare neoplasms of the lung with good prognosis but diagnosis may be demanding since there is no exclusive modality alone to clearly differentiate a PC tumor. The purpose of this study is to establish the diagnostic features of somatostatin receptor scintigraphy (SRS), comparatively (where available) with (18)FDG PET/CT (PET/CT) correlated with histopathologic findings.